Free Trial

Sagimet Biosciences (SGMT) SEC Filings & 10K Form

Sagimet Biosciences logo
$4.52 +0.11 (+2.49%)
(As of 11/20/2024 ET)

Recent Sagimet Biosciences SEC Filings

DateFilerForm TypeView
11/14/2024
6:55 PM
Point72 Asset Management, L.P. (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:27 PM
BAKER BROS. ADVISORS LP (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
11/14/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
11:15 PM
Sagimet Biosciences (Filer)
Form EFFECT
08/16/2024
3:53 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:27 PM
Sagimet Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/14/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
7:06 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:05 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:24 PM
Kemble George (Reporting)
Sagimet Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:05 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:05 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:06 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:26 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:07 AM
Sagimet Biosciences (Filer)
Form 8-K/A
06/06/2024
5:03 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
6:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:05 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:00 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
7:06 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
5:16 AM
Sagimet Biosciences (Filer)
Form DEF 14A
04/18/2024
5:19 AM
Sagimet Biosciences (Filer)
Form DEFA14A
04/18/2024
5:21 AM
Sagimet Biosciences (Filer)
Form ARS
04/03/2024
7:15 PM
Sagimet Biosciences (Issuer)
Walbert Timothy P (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
7:17 PM
Hoelscher Paul W. (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:19 PM
Sagimet Biosciences (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:13 PM
Hoelscher Paul W. (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2024
3:08 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
6:00 AM
Sagimet Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2024
5:37 AM
Sagimet Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
5:19 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
02/14/2024
5:10 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/14/2024
5:20 AM
KPCB PANDEMIC & BIO DEFENSE FUND LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/09/2024
8:49 AM
FMR LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
02/05/2024
3:34 PM
Point72 Asset Management, L.P. (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/02/2024
3:36 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:55 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:56 PM
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
01/31/2024
3:57 PM
BASKETT FOREST (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:59 PM
KERINS PATRICK J (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:00 PM
Sagimet Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:05 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
11:15 PM
Sagimet Biosciences (Filer)
Form EFFECT
01/24/2024
5:08 AM
Sagimet Biosciences (Filer)
Form S-1/A
01/24/2024
5:10 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
4:31 PM
Sagimet Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/22/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:16 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:23 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:25 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:15 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:21 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:22 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
8:59 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SGMT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners